Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial

被引:556
作者
Wawer, MJ
Sewankambo, NK
Serwadda, D
Quinn, TC
Paxton, LA
Kiwanuka, N
Wabwire-Mangen, F
Li, CJ
Lutalo, T
Nalugoda, F
Gaydos, CA
Moulton, LH
Meehan, MO
Ahmed, S
Gray, RH
机构
[1] Columbia Univ, Sch Publ Hlth, Ctr Populat & Family Hlth, New York, NY 10032 USA
[2] Makerere Univ, Dept Med, Kampala, Uganda
[3] Makerere Univ, Clin Epidemiol Unit, Kampala, Uganda
[4] Makerere Univ, Inst Publ Hlth, Dept Populat & Family Hlth Sci, Kampala, Uganda
[5] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21205 USA
[7] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[8] Uganda Virus Res Inst, Rakai Project, Entebbe, Uganda
[9] NIAID, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S0140-6736(98)06439-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The study tested the hypothesis that community-level control of sexually transmitted disease (STD) would result in lower incidence of HIV-1 infection in comparison with control communities. Methods This randomised, controlled, single-masked, community-based trial of intensive STD control, via home-based mass antibiotic treatment, took place in Rakai District, Uganda. Ten community clusters were randomly assigned to intervention or control groups. All consenting residents aged 15-59 years were enrolled; visited in the home every 10 months; interviewed; asked to provide biological samples for assessment of HIV-1 infection and STDs; and were provided with mass treatment (azithromycin, ciprofloxacin, metronidazole in the intervention group, vitamins/anthelmintic drug in the control). intention-to-treat analyses used multivariate, paired, cluster-adjusted rate ratios. Findings The baseline prevalence of HIV-1 infection was 15.9%. 6602 HIV-1-negative individuals were enrolled in the intervention group and 6124 in the control group. 75.0% of intervention-group and 72.6% of control-group participants provided at least one follow-up sample for HIV-1 testing. At enrolment, the two treatment groups were similar in STD prevalence rates. At 20-month follow-up, the prevalences of syphilis (352/6238 [5.6%) vs 359/5284 [6.8%]; rate ratio 0.80 [95% CI 0.71-0.89]) and trichomoniasis (182/1968 [9.3%] vs 261/1815 [14.4%]; rate ratio 0.59 [0.38-0.91]) were significantly lower in the intervention group than in the control group. The incidence of HIV-1 infection was 1.5 per 100 person-years in both groups (rate ratio 0.97 [0.81-1.16]). In pregnant women, the follow-up prevalences of trichomoniasis, bacterial vaginosis, gonorrhoea, and chlamydia infection were significantly lower in the intervention group than in the control group. No effect of the intervention on incidence of HIV-1 infection was observed in pregnant women or in stratified analyses. Interpretation We observed no effect of the STD intervention on the incidence of HIV-1 infection. In the Rakai population, a substantial proportion of HIV-1 acquisition appears to occur independently of treatable STD cofactors.
引用
收藏
页码:525 / 535
页数:11
相关论文
共 38 条
  • [1] Brookmeyer R, 1998, STAT MED, V17, P2121, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2121::AID-SIM907>3.0.CO
  • [2] 2-S
  • [3] Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: Implications for diagnostic testing and screening
    Buimer, M
    VanDoornum, GJJ
    Ching, S
    Peerbooms, PGH
    Plier, PK
    Ram, D
    Lee, HH
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (10) : 2395 - 2400
  • [4] SAFETY OF METRONIDAZOLE IN PREGNANCY - A METAANALYSIS
    BURTIN, P
    TADDIO, A
    ARIBURNU, O
    EINARSON, TR
    KOREN, G
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (02) : 525 - 529
  • [5] *CDCP, 1993, MMWR-MORBID MORTAL W, V43, P1
  • [6] Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2
  • [7] Reduction of concentration of HIV-1, in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1
    Cohen, MS
    Hoffman, IF
    Royce, RA
    Kazembe, P
    Dyer, JR
    Daly, CC
    Zimba, D
    Vernazza, PL
    Maida, M
    Fiscus, SA
    Eron, JJ
    Nkata, E
    Kachenje, E
    Banda, T
    Mughogho, G
    Koller, C
    Schock, J
    Chakraborty, H
    Dallabetta, G
    Gilliam, B
    [J]. LANCET, 1997, 349 (9069) : 1868 - 1873
  • [8] Dallabetta GA, 1998, SEX TRANSM INFECT, V74, pS1
  • [9] The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire
    Ghys, PD
    Fransen, K
    Diallo, MO
    EttiegneTraore, V
    Coulibaly, IM
    Yeboue, KM
    Kalish, ML
    Maurice, C
    Whitaker, JP
    Greenberg, AE
    Laga, M
    [J]. AIDS, 1997, 11 (12) : F85 - F93
  • [10] GRAY RH, 1998, 12 WORLD AIDS C GEN